A GLP-1 weight-loss medication like Zepbound or Wegovy lists at roughly $1,000 to $1,350 a month — but almost no one has to pay that. What you actually pay depends far more on your type of coverage than on your income.
This tool asks up to three quick questions and points you to the lowest-cost route for your situation — savings card, manufacturer cash-pay, patient assistance, or the Medicare pathway — with the exact next step. No name, no email, nothing saved. About 40 seconds.
How this tool decides what to show you
The screener matches the medication you’re asking about and, most importantly, your type of coverage against the programs that lower the cost of GLP-1 weight-loss medications, then lists them in the order most likely to work for you. It doesn’t decide whether you qualify; only the programs can do that. What it removes is the confusing part: knowing which route even applies to someone in your situation.
GLP-1 access works differently from most medication-cost problems, and the difference trips people up. For a cure like hepatitis C, nearly everyone has a path. For GLP-1 weight-loss drugs, coverage is genuinely uneven — and the rule that surprises the most people is that Medicare cannot pay for these drugs for weight loss at all. So this tool leads with coverage type, because that, not income, is what decides your cheapest legal route.
- Coverage type matters more than income. The savings cards are only for commercial insurance; cash-pay and assistance are the routes for everyone else.
- Medicare won’t cover it for weight loss. By law, Part D can only cover a GLP-1 when it’s prescribed for a separate approved condition, like heart-risk reduction or sleep apnea.
- The list price is almost never what you pay. Buying directly from the maker runs a few hundred dollars a month, not the ~$1,000–$1,350 sticker.
- Uninsured can still mean free. Lilly Cares and NovoCare’s assistance programs provide the medication at no cost to income-qualifying patients.
Related weight-management cost guides
Once you know your route, these guides walk through the specific numbers: what Wegovy costs, what Mounjaro and Zepbound cost, how to handle Wegovy without insurance, and the Medicare GLP-1 Bridge. For the full picture, see our complete guide to weight-management medications, costs, and access.
Common questions
Does insurance cover Zepbound or Wegovy for weight loss?
Sometimes, but coverage for weight loss is inconsistent. Many commercial (job-based or private) plans now cover GLP-1 medications for obesity, but a large share still exclude weight-loss drugs entirely, even when they cover the same drug for diabetes. Whether yours is covered depends on your specific plan’s formulary. If it is covered, the manufacturer savings card can bring your cost to as little as $25 a month; if it is excluded, you’re looking at cash-pay or patient assistance instead.
Does Medicare cover Wegovy or Zepbound for weight loss?
Not for weight loss alone. By law, Medicare Part D cannot cover a drug used only for weight loss. Medicare can cover these medications when they’re prescribed for a separate approved condition, such as reducing cardiovascular risk (Wegovy) or moderate-to-severe obstructive sleep apnea with obesity (Zepbound). If you qualify under one of those conditions, a temporary Medicare GLP-1 Bridge program can bring the cost to about $50 a month. If you don’t, Medicare won’t pay, and the manufacturer savings cards can’t be used with Medicare.
How can I get a GLP-1 medication if my insurance doesn’t cover weight loss?
You have two main routes. First, the manufacturers sell directly to cash-pay patients: Eli Lilly’s LillyDirect offers Zepbound vials and pens starting around $299 to $499 a month depending on dose, and Novo Nordisk’s NovoCare Pharmacy offers Wegovy for roughly $349 to $499 a month. Second, if you’re uninsured and meet income limits, the Lilly Cares and NovoCare patient assistance programs can provide the medication free. Both cost far less than the roughly $1,000 to $1,350 monthly list price.
Can I use a Zepbound or Wegovy savings card with Medicare or Medicaid?
No. Federal anti-kickback law bars manufacturer savings cards for anyone with Medicare, Medicaid, TRICARE, VA, or any other government insurance. Those cards are for people with commercial (private or job-based) insurance only. If you have government coverage, your routes are the Medicare GLP-1 Bridge (if you qualify by condition), cash-pay through the manufacturer pharmacy, or a patient assistance program.
How much does Zepbound or Wegovy cost without insurance?
The list price is roughly $1,000 to $1,350 a month, but almost no one needs to pay that. Buying directly from the manufacturer is far cheaper: Zepbound through LillyDirect starts around $299 a month for the lower doses (higher doses more), and Wegovy through NovoCare Pharmacy runs about $349 to $499 a month. If you’re uninsured and income-qualify, the manufacturer patient assistance programs may provide it free. Prices and terms change, so confirm the current figure on the manufacturer’s site.
Is compounded semaglutide or tirzepatide a safe way to save money?
Be cautious. Compounded versions are often advertised at low prices, but the FDA does not review compounded drugs for safety, effectiveness, or quality, and the large-scale compounding that was allowed during the 2023 to 2025 shortages has been wound down as the FDA declared the shortages resolved. Because brand cash-pay prices have dropped sharply, the manufacturer routes are now often close in price and come with a verified supply chain. Talk to your prescriber before using a compounded product.
Does this tool save my name, email, or answers?
No. Nothing you enter is stored or sent anywhere. The tool runs entirely inside your browser — no account, no submission form, no logging, not even anonymous logging. Close the page and your answers are gone.
Do I need a prescription to get a GLP-1 weight-loss medication?
Yes. Zepbound and Wegovy are prescription-only. A prescriber has to confirm the medication is appropriate for you, usually based on your body mass index and any weight-related health conditions. If you don’t have a prescriber, both manufacturers list telehealth options that can evaluate you and, if appropriate, prescribe, and a primary-care provider can also prescribe these medications.
Is SunnyPharma a pharmacy, and is this medical advice?
No. SunnyPharma is an independent, physician-reviewed health-cost-education resource — not a pharmacy and not a provider. This tool helps you find and navigate cost and access programs. It doesn’t dispense medication, determine eligibility, or replace advice from your own doctor or pharmacist.
How we built this tool.
Program facts are verified against primary sources: the Eli Lilly Zepbound savings and self-pay pages, the Novo Nordisk NovoCare and Wegovy savings pages, Medicare.gov coverage rules for weight-loss drugs, and the Lilly Cares and NovoCare patient assistance program terms. Manufacturer prices and savings-card terms change and are currently set to expire December 31, 2026, so the tool routes to authoritative manufacturer pages rather than hard-coding figures that go stale. Facts verified for 2026; reverify after Jan 2027.
Read our editorial policy →Sources
- Eli Lilly — Zepbound Savings & Insurance Options: zepbound.lilly.com/savings
- Eli Lilly — LillyDirect self-pay pharmacy: lilly.com/lillydirect
- Novo Nordisk — Wegovy Savings Offer (NovoCare): novocare.com
- Novo Nordisk — Wegovy cost & coverage: wegovy.com
- Medicare — Weight-loss drug coverage rules: medicare.gov
- Lilly Cares Foundation patient assistance: lillycares.com
- CDC — Obesity information: cdc.gov/obesity
- 2026 HHS Poverty Guidelines, ASPE: aspe.hhs.gov
Medical & eligibility disclaimer: Educational content only — not medical, legal, or financial advice, and not a determination of eligibility. Program rules and prices change; confirm current details with each program before acting. Consult a licensed healthcare provider or pharmacist about your treatment.